1-3 of 3
James W. Watters
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 1799: Targeted murine double minute 2 (MDM2) inhibition results in dramatic tumor regression in an MDM2-amplified glioblastoma multiforme (GBM) xenograft model

Ann C. Mladek, Isabelle Meaux, Katrina Bakken, Pascal Pannier, Cedric Barriere, James W. Watters, Laurent R.J. Debussche, Jann N. Sarkaria
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 1799.
https://doi.org/10.1158/1538-7445.AM2014-1799
Published: 01 October 2014
View articletitled, Abstract 1799: Targeted murine double minute 2 (MDM2) inhibition results in dramatic tumor regression in an MDM2-amplified glioblastoma multiforme (GBM) xenograft model
Journal Articles

Abstract 107: Genome-wide analysis reveals that cMET is a driver of RAS signaling and implicates RAS activation status as a predictor for response to cMET inhibitors

Andrey Loboda, Misha Nebozhyn, Theresa Zhang, Igor Feldman, Mark Ayers, Cloud Paweletz, John Reilly, Hongyue Dai, Pearl Huang, James W. Watters
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 107.
https://doi.org/10.1158/1538-7445.AM10-107
Published: 15 April 2010
View articletitled, Abstract 107: Genome-wide analysis reveals that cMET is a driver of RAS signaling and implicates RAS activation status as a predictor for response to cMET inhibitors
Journal Articles

De novo Discovery of a γ-Secretase Inhibitor Response Signature Using a Novel In vivo Breast Tumor Model

James W. Watters, Chun Cheng, Pradip K. Majumder, Ruojie Wang, Sireesha Yalavarthi, Carol Meeske, Lingxin Kong, Wenping Sun, Jie Lin, Joerg Heyer, Chris Ware, Christopher Winter, John F. Reilly, Tim Demuth, Steve Clark, M. Isabel Chiu, Murray O. Robinson, Nancy Kohl, Karuppiah Kannan
Journal: Cancer Research
Cancer Res (2009) 69 (23): 8949–8957.
https://doi.org/10.1158/0008-5472.CAN-09-1544
Published: 30 November 2009
View articletitled, De novo Discovery of a γ-Secretase Inhibitor Response Signature Using a Novel In vivo Breast Tumor Model
Open the PDF for De novo Discovery of a γ-Secretase Inhibitor Response Signature Using a Novel In vivo Breast Tumor Model in another window
Includes: Supplementary data